🚨 FDA committee votes 'YES' on 6 of 7 peptides — here's what happens next, with Dr. Alex Tatem
Hearings & news coverage — 🚨 FDA committee votes 'YES' on 6 of 7 peptides — here's what happens next, with Dr. Alex Tatem
Channel: Hims House and Dr. Alex Tatem · Our label: Hearing coverage and news reporting · Source: youtube.com/watch?v=IQCQFeNwnlo
What this video covers
You might know their CEO, Max Marion, from his past appearances on this show. But honestly, the blood test was the least interesting part of the whole thing. And now I’m able to chat with an AI that has my entire medical history. I even compared the Superpower AI against Chat GPT and Claude.
Summary drawn from this video’s own transcript (banked in our research library, pulled 2026-11-07). Claims below are the speaker’s — attributed, not endorsed. This site publishes no dosing, protocol, or sourcing information.
Key points, in the speaker’s own framing
- basically real world evidence talking about how these compounds were used safely for almost a decade before they were taken away from patients.
- Can you say more about what has to happen next in order for in order for 503As to be able to lawfully compound the peptides?
- Adding in uh KPV on top of your GHK, BPC, and TB500.
- the there were some briefing documents that came out maybe 3 weeks ago, four weeks ago during which the FDA recommended against all seven peptides, adding all seven peptides to the bulk list.
- You said the FDA is in charge of the final rule, and that’s true, but RFK is in charge of the FDA, effectively, HHS, but they’re in charge of the FDA.
- Now, um they they are doing that and the FDA could try to crack down, but it’s also a little hit or miss because 503A compounders are not technically regulated directly by the FDA.
Read next
Educational information only — not medical advice. Peptides discussed on this page include substances that are not FDA-approved.